Among the genetic abnormalities reported in ER+ breast cancer, mutations are commonly detected in genes encoding the subunits of the BAF chromatin remodeling complexes and ARID1A is the most frequently mutated one in BAF (Garraway and Lander, 2013). Here, ARID1A is linked to breast carcinoma.